Your browser doesn't support javascript.
loading
Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours.
Hubina, Erika; Nanzer, Alexandra M; Hanson, Matthew R; Ciccarelli, Enrica; Losa, Marco; Gaia, Daniela; Papotti, Mauro; Terreni, Maria Rosaria; Khalaf, Sahira; Jordan, Suzanne; Czirják, Sándor; Hanzély, Zoltán; Nagy, György M; Góth, Miklós I; Grossman, Ashley B; Korbonits, Márta.
Affiliation
  • Hubina E; Department of Endocrinology, William Harvey Research Institute, Barts and the London Medical School, Queen Mary College, Charterhouse Square, London EC1M 6BQ, UK.
Eur J Endocrinol ; 155(2): 371-9, 2006 Aug.
Article in En | MEDLINE | ID: mdl-16868153
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Pituitary Neoplasms / Octreotide / Adenoma / Antineoplastic Agents, Hormonal / MAP Kinase Signaling System / Cyclin-Dependent Kinase Inhibitor p27 Limits: Animals / Humans Language: En Journal: Eur J Endocrinol Journal subject: ENDOCRINOLOGIA Year: 2006 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Pituitary Neoplasms / Octreotide / Adenoma / Antineoplastic Agents, Hormonal / MAP Kinase Signaling System / Cyclin-Dependent Kinase Inhibitor p27 Limits: Animals / Humans Language: En Journal: Eur J Endocrinol Journal subject: ENDOCRINOLOGIA Year: 2006 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom